Exercise has profound benefits for brain function in animals and humans. In rodents, voluntary wheel running increases the production of new neurons and upregulates neurotrophin levels in the hippocampus, as well as improving synaptic plasticity, memory function and mood. The underlying cellular mechanisms, however, remain unresolved. Recent research indicates that peripheral organs such as skeletal muscle, liver and adipose tissue secrete factors during physical activity that may influence neuronal function. Here we used an in vitro cell assay and proteomic analysis to investigate the effects of proteins secreted from skeletal muscle cells on adult hippocampal neural progenitor cell (aNPC) differentiation. We also sought to identify the relevant molecules driving these effects. Specifically, we treated rat L6 skeletal muscle cells with the AMP-kinase (AMPK) agonist 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) or vehicle (distilled water). We then collected the conditioned media (CM) and fractionated it using high-performance liquid chromatography (HPLC). Treatment of aNPCs with a specific fraction of the AICAR-CM upregulated expression of doublecortin (DCX) and Tuj1, markers of immature neurons. Proteomic analysis of this fraction identified proteins known to be involved in energy metabolism, cell migration, adhesion and neurogenesis. Culturing differentiating aNPCs in the presence of one of the factors, glycolytic enzyme glucose-6-phosphate isomerase (GPI), or AICAR-CM, increased the proportion of neuronal (Tuj1 + ) and astrocytic, glial fibrillary acidic protein (GFAP + ) cells. Our study provides further evidence that proteins secreted from skeletal muscle cells may serve as a critical communication link to the brain through factors that enhance neural differentiation.
Introduction
Environmental enrichment results in structural and functional changes in the brain and behavior (Kempermann et al., 1997; van Praag et al., 1999; Nithianantharajah and Hannan, 2006; Eisinger and Zhao, 2017) . A critical component of enrichment is physical activity (van Praag, 2008; Kobilo et al., 2011a; Gregoire et al., 2014) . In rodents, voluntary wheel running increases neurotransmitters, growth factors, vascularization and adult neurogenesis in the hippocampus (Vivar et al., 2013; Ryan and Kelly, 2016) . However, the peripheral factors that may trigger running-induced adult hippocampal neurogenesis remain unclear. Parabiosis studies between young and aged animals show https://doi.org/10.1016/j.neuropharm.2018.10.041 Received 28 November 2017; Received in revised form 30 October 2018; Accepted 31 October 2018 pound extend to brain function in mice, with short-term administration resulting in enhanced adult neurogenesis, brain-derived neurotrophin (BDNF) levels and spatial memory function (Kobilo et al., 2011b; Guerrieri and van Praag, 2015) . In mice with a muscle-specific, dominant negative expression of α2-AMPK subunit (AMPKDN) (Zwetsloot et al., 2008) , there was no improvement in spatial memory function after AICAR administration, suggesting muscle AMPK activation may be required (Kobilo et al., 2014) . Based on these findings, we treated L6 muscle cells with AICAR in culture followed by proteomic analysis of the CM. We identified a novel myokine, Cathepsin B as a mediator of exercise-induced enhancement of hippocampal plasticity and memory function (Moon et al., 2016) .
In the present study we aim to identify additional factors that may affect neural function. We utilized a novel and complementary approach to our previous research. We similarly treated L6 myoblasts with AICAR or vehicle and collected the CM. In this study, however, we fractionated the media by HPLC and subsequently used it to treat adult neural progenitor cells (aNPCs). A specific fraction of the AICAR CM increased aNPC expression of DCX and Tuj1, markers of immature neurons. Proteomic analysis of this fraction revealed proteins known to be involved in cell migration, adhesion and neurogenesis. Culturing differentiating aNPCs in AICAR-CM or glucose metabolism regulator GPI, increased the proportion of neuronal and glial cells. Altogether, we observed that secretory proteins from skeletal muscle induced by AICAR treatment influences in vitro neural differentiation.
Methods and materials

Cell culture and preparation of CM
L6 skeletal myoblast cells (ATCC CRL-1458, Virginia, USA) were grown in Dulbecco's Modified Eagle's Medium (DMEM; Gibco, NY, USA) supplemented with fetal bovine serum (FBS) to a final concentration of 10%. The cells were passaged every second day and confluency was maintained at less than 80% to prevent spontaneous differentiation. To induce differentiation, cells (4 × 10 4 cells/mL) were placed into DMEM supplemented with 2% horse serum (HS) for 8 days, with medium refreshed every other day. Differentiation status was routinely monitored under a microscope (Axiovert S100; Zeiss, Germany). On day 9, L6 myotubes were washed three times with DPBS. CM was prepared by adding 12 ml of the unsupplemented DMEM, with or without 100 μM AICAR, to the myotubes and incubating them for 6 h in a 37̊C CO 2 incubator. The cultured medium was filtered using a 0.22 μm filter and then the filtered medium was concentrated 1:10 by 3,000NMWL centrifugal filter devices (Millipore, MA, USA). Protein concentration was measured using Bradford assay.
Reverse phase HPLC
High-performance liquid chromatography (HPLC; LC20AD, Shimadzu) with a C4 column (2.1 × 150 mm 2 , 5 mm; Vydac, The Separations Group, Hesperia, CA) was used to analyze the 1% DMSO-DW eluted secretomes. Solvent A was composed of 0.1% TFA (Sigma-Aldrich, St. Louis, MO, USA) in ultrapure water (Fisher Scientific, Pittsburgh, PA, USA), and solvent B was composed of 0.1% TFA in ACN. A linear gradient with a flow rate of 0.3 mL/min was employed, using the following gradient: 1% B (at 7 min), 60% B (at 30 min), 100% B (at 42 min) for 10 min, followed by equilibration with 1% B. The observed UV wavelength was 215 nm. Fractions were concentrated with vacuum centrifuge (Speedvac, Savant, USA) and reconstituted with distilled water (D.W.).
In-solution digestion and mass spectrometry analysis
Approximately 250 μg of protein from vehicle treated CM and AICAR treated CM mixed secretome were subjected to in solution digestion as described previously (Harsha et al., 2008) . The proteins in solution were reduced with 5 mM dithiothreitol followed by alkylation with 10 mM iodoacetamide. Digestion was carried out using trypsin (modified sequencing grade; Promega, Madison, WI) at 37°C for 16 h. Tandem mass tag (TMT; TMT Mass Tagging kits and reagent, Thermo scientific, Rockford, IL) labeling was carried out as per the manufacturer instructions with minor modifications. Briefly, trypsinized peptides from two conditions were reconstituted in 50 mM TEABC buffer and mixed with the TMT reagent and incubated at RT for 1 h. After the labeling, all samples were pooled and desalted using Sep-Pak C18 cartridges. Peptides were analyzed on an LTQ-Orbitrap Elite mass spectrometer (Thermo Electron, Bremen, Germany) interfaced with Easy-nLC II nanoflow LC system (Thermo Scientific, Odense, Denmark). The pooled TMT labeled peptides were reconstituted in 0.1% formic acid and loaded onto a trap column (75 μm × 2 cm) packed in-house with Magic C18 AQ (Michrom Bioresources, Inc., Auburn, CA, USA). Peptides were resolved on an analytical column (75 μm × 50 cm) at a flow rate of 300 nL/min using a linear gradient of 10-35% solvent B (0.1% formic acid in 95% acetonitrile) over 90 min. The total run time including sample loading and column reconditioning was 120 min. Data dependent acquisition with full scans in 350-1700 m/z range was carried out using an Orbitrap mass analyzer at a mass resolution of 120,000 at 400 m/z. Fifteen most intense precursor ions from a survey scan were selected for MS/MS fragmentation using higher energy collisional dissociation (HCD) fragmentation with 32% normalized collision energy and detected at a mass resolution of 30,000 at 400 m/z. Automatic gain control for full MS was set to 1 × 10 6 for MS and 5 × 10 4 ions for MS/MS with a maximum ion injection time of 100 ms.
Dynamic exclusion was set to 30 s and singly charged ions were rejected. Internal calibration was carried out using lock mass option (m/z 445.1200025) using ambient air.
Adult neural progenitor cell culture
Primary NPCs were isolated from the dentate gyrus of 8-to 10-week-old male on C57Bl/6 genetic background as described previously Guo et al., 2012a,b) . Cells independently isolated from three mice served as biological replicates (n = 3). We used only early passage cells (between passages 4 and 10). Differentiation of aNPCs to neurons and astrocytes was carried out as described (Luo et al., 2010; Guo et al., 2011a; Guo et al., 2011b) . Briefly, neurospheres with average diameter of 250 μm were disassociated with trypsin and the aNPCs were plated in 24 well plates (Fisher Scientific, 87721) containing poly-L-ornithine and laminin-coated coverslips and cell proliferation medium at the density of 1 × 10 5 cells/well. At 24 h post plating, differentiation was initiated by mitogen withdrawal. The differentiation media included the following chemical treatments and was partially replaced daily. Specifically, Vehicle CM or AICAR CM (10 μg/ ml) or recombinant protein glucose-6-phosphate isomerase (GPI), (0.5 or 1 μg/ml, MBS95581l, Mybiosource) were added to some of the NPCs. Retinoic acid (1 μM, Sigma-Aldrich, R-2625)/forskolin (1 μM, SigmaAldrich, F-6886) initiated differentiation was used as a positive control and added to wells that were not used for chemical treatment. At 4 days post-differentiation, cells were fixed using 4% PFA for 30 min. Immunocytochemistry staining was carried out as described . Briefly, cells were pre-blocked using DPBS containing 5% normal goat serum (VECTOR, S-1000) and 0.1% Triton X-100 for 30 min, followed by overnight incubation with primary antibodies: mouse anti-Tuj1 (1:2000, Covance, E10408LF) and rabbit anti-GFAP (1:3000, Dako, Z0334). After washing with DPBS, cells were incubated with secondary antibodies that included goat anti-mouse 568 (1:3000, Invitrogen, A11031) and goat anti-rabbit 568 (1:3000, Invitrogen, A11036) followed by counterstaining with DAPI. After the cells were mounted with VECTASHIELD (VECTOR, H-1000), the numbers of Tuj1, GFAP-positive cells were quantified using an Olympus BX51 microscope using an unbiased stereology method with assistance from StereoInvestigator software. The percentage of differentiated cells was calculated as the number of Tuj1-or GFAP-labeled cells divided by the total number of cells stained with DAPI. Scientists who were blinded to experimental conditions performed quantification. 
MTT and RT-PCR assays
MTT cell viability assay
Cell viability was quantified by using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a yellow tetrazole; Sigma-Aldrich, St. Louis, MO, USA) reagent. MTT stock solution (5 mg/ ml) was prepared in DPBS (GIBCO) and added to the culture medium at a final concentration of 1 mg/ml. After 90 min incubation, the medium was removed, and the chromogen in the cells was dissolved in DMSO containing 0.01 N NaOH. The absorbance at 570 nm was measured using a 96-well microplate spectrophotometer (Thermo scientific, Rockford, IL).
Semiquantitative RT-PCR analysis
Total RNA was extracted using a total RNA extraction kit (Ribozol, Amresco). First-strand cDNA was synthesized by RT using oligo(dT) primers and SuperScript II reverse transcriptase (Invitrogen). cDNA was amplified for 15-25 cycles using mouse DCX (Forward (F):5′-AAGTG ACCAACAAGGCTAT -3′, Reverse (R):5′-TCATTGTGTTTTCCCGGA-3′), Tuj1 (F):5′-CGCCTTTGGACACCTATTCAG -3′, (R):5′-TTCTCACACTCT TTCCGCAC -3′), NeuN (F):5′-GTAGAGGGACGGAAAATTGAGG -3′, (R): 5′-GGGAAACTGGTCACTGCATAG -3′) and HSP90 (F:5′-GACCAAGGC TGACCTCATAAA -3′, R:5′-GACCAAGGCTGACCTCATAAA -3′) genespecific primers. For real-time RT-PCR, total RNA (100 ng) was amplified using the PerfeCTa SYBR Green FastMix (Quanta Biosciences) and ECO PCR system (Illumina).
Western blot analysis of cultured medium of L6 muscle cells and densitometry
CM (Please see 2.1. Cell culture and preparation of CM) collected from L6 muscle cells was mixed with 1:1 ratio RIPA buffer (Millipore), Protease/Phosphatase Inhibitor Cocktail (Cell Signaling Technology, Danvers, MA) and sample buffer (Bio-rad). For Western blot analysis, containing equal amounts of protein from each fraction were subjected to SDS-PAGE and transferred to a NC membrane (Millipore). The membranes were blocked with 5% nonfat dried milk in PBS containing 0.1% Triton X-100 and then incubated with anti-fibronectin (1:1000, ab2413, Abcam) at 4°C overnight. Secondary antibody linked to Infrared dye (800 anti-rabbit) were used at a dilution of 1:5000. Specific signals were visualized by Odyssey (Amersham Biosciences). Ponceau staining was used as a loading control. Image J analysis was performed for the densitometry of immunoblot images. The gel analysis tool was used to obtain the absolute intensity for each band (commands used: Analyze > Gel > Select First lane > plot lane > wand tool).
Bioinformatics analysis
DAVID Bioinformatics Resources 6.7 was used for functional annotation, based on KEGG_Pathway terms. The count threshold was set at 3 and the EASE value was set at 0.1. (Cannistraci et al., 2013) .
Data analysis
Statistical analyses were carried out using Statview and GraphPad software. Comparisons between groups were performed with one-way analysis of variance (ANOVA) followed by Fisher's PLSD or Tukey's post-hoc tests. All values were expressed as means ± S.E.M.
Results
Fractionation of conditioned medium from skeletal muscle cell line L6 treated with AICAR
A small-molecule AMPK agonist, AICAR, was used to treat the L6 Rattus skeletal muscle cell line to mimic AMPK modulation of skeletal muscle during the exercise. CM, which contained factors secreted by the skeletal muscle cells, was collected. HPLC equipped with a C4 column was used to fractionate the CM collected from AICAR and vehicletreated cells and to compare differentially secreted proteins (Fig. 1A) . The resulting chromatograms from vehicle-treated and AICAR-treated cells displayed distinct peaks at retention times between 7 and 9 min after injection (Fig. 1B and C) . These peaks suggested the presence of uniquely secreted factors in the CM of AICAR-treated muscle cells. Subsequently, the effects of these fractions on neural cell development were evaluated.
Treatment of aNPCs with AICAR CM fraction increases DCX and Tuj1 expression
We first investigated whether treatment of aNPCs with fractions from AICAR-or vehicle-treated CM affects cell viability using a MTT assay. Incubating aNPCs for 24 h with various fractions of CM did not significantly impact aNPC viability, whereas treatment with FBS (10%) enhanced cell viability as compared to all the other conditions (F (6,21) = 17.75, p < 0.0001; Fig. 2A ). We next assessed the mRNA expression level of well-established neuronal differentiation markers, including Tuj1, doublecortin (DCX) and NeuN. Expression of these markers was evaluated by real-time PCR. We found that fraction A11 of AICAR-treated skeletal muscle cell CM significantly increased the expression of immature neuron markers, Tuj1 (F (5,12) = 3.29, p < 0.05; Fig. 2B ) and DCX (F (5,12) = 3.17, p < 0.05; Fig. 2C) , as compared to non-treated (NT) cells, and cells exposed to other CM fractions. These H.Y. Moon et al. Neuropharmacology 145 (2019) 123-130 findings suggest that a specific factor or factors is present in fraction A11 that may initiate differentiation. This fraction did not increase expression of the mature neuronal marker NeuN. Treatment with 0.5% FBS did enhance NeuN expression (F (5,12) = 3.52, p < 0.05), consistent with previous studies (Guo et al., 2014) , (Fig. 2D) .
Identification of proteins present in CM from AICAR-treated cells
We used LC-MS/MS to identify differentially secreted proteins induced by AICAR treatment of muscle cells. We focused on HPLC "fraction A11" because that fraction enhanced DCX and Tuj1 expression in adult NPCs. To quantify differentially secreted proteins, we generated trypsin-digested peptides from fraction A11, labeled them with stable isotopes, and performed LC/MS. Using this approach, we identified 74 total proteins. Twelve of the proteins were found in both the vehicle and AICAR-treated cells (Supplementary Table 1) , resulting in 38 differentially secreted proteins in the AICAR sample ( Fig. 3A and B) . Nine of these proteins had peptide coverage greater than 5% (highlighted in green).
To investigate the functional features of the identified proteins from the AICAR-treated CM, we conducted a functional analysis of all identified proteins using KEGG pathway terms (Fig. 3C) . We found that proteins secreted by AICAR-treated cells cluster into eight overlapping categories: glycolysis/gluconeogenesis, phenylalanine metabolism, complement and coagulation cascades, regulation of actin cytoskeleton, tyrosine metabolism, adherens junction, focal adhesion, and leukocyte transendothelial migration. Many of these proteins are cytoskeletal associated (e.g. actin, vimentin and actinin4), or involved in energy metabolism (e.g. pyruvate kinase, phosphoglycerate kinase and L-lactate dehydrogenase A chain-like). One protein secreted by AICAR-treated cells, ventricular zone-expressed PH protein (VEPH), has been reported to be expressed in the embryonic mouse brain (Muto et al., 2004) . We note, however, that the peptide coverage of the protein in our AICAR CM was less than 1% (Fig. 3B) .
Evaluation of candidate proteins
To validate the proteomics data, we evaluated whether candidate factor, fibronectin, was increased in AICAR-CM. Protein levels were significantly elevated as compared to vehicle-CM (t (4) = 3.41, p < 0.05; Supplementary Fig. 1, Supplementary Table 1) . In addition, we tested whether another protein, glycolytic enzyme glucose-6-phosphate isomerase (GPI), could affect aNPC differentiation. Specifically, we withdrew differentiation-inhibitory mitogens (FGF2 and EGF) from the aNPC culture media and treated differentiating aNPCs with either vehicle-CM, AICAR-CM, Retonoic acid/Forskolin (RA/FSK) or recombinant GPI. Both concentrations of GPI (0.5 μg/ml and 1 μg/ml), AICAR CM and RA/FSK significantly increased the number of Tuj1-positive neuronal cells as compared to Mock and Vehicle CM treatment conditions (F (5,12) = 10.43, p < 0.0005), (Fig. 4A,C ,E,G). GPI (1 μg/ ml) and AICAR CM also enhanced gliogenesis as evidenced by an increased number of GFAP-positive astrocytes as compared to Mock and Vehicle CM treatment F (5,12) = 27.83, p < 0.0001), (Fig. 4B,D,F,H) .
Discussion
In the present study we employed an in vitro model to develop a novel approach to understanding the cellular mechanisms underlying the benefits of exercise for memory and mood. Specifically, we aimed to identify novel secreted factors from muscle that may have exercise-like effects on neural cell properties, such as enhancement of survival and differentiation. CM was collected from AICAR-or vehicle-treated muscle cells. Using HPLC fractionation of CM, we observed differentially secreted proteins from AICAR-and vehicle-treated cells. Treatment of aNPCs with various fractions from AICAR-and vehicletreated cells did not affect viability of aNPCs; however, at least one fraction, Fraction A11, enhanced expression of Tuj1 and DCX, markers of immature neurons. Using liquid chromatography-mass spectrometry, we identified the proteins in the active fraction from AICAR-treated CM. KEGG-pathway analysis revealed that the majority of these proteins are associated with cytoskeletal and energy metabolism pathways, H.Y. Moon et al. Neuropharmacology 145 (2019) 123-130 and that one of these factors, glycolytic enzyme GPI, enhanced neuronal and glial differentiation of adult neural progenitor cells. Human skeletal muscle cells can secrete more than 300 proteins (Hartwig et al., 2014) . Many of these myokines affect other tissues such as liver, bone, adipose tissues and immune cells (Pedersen and Febbraio, 2012; Hoffmann and Weigert, 2017) . Only a few myokines, such as CTSB, Irisin, Il-6 and vascular endothelial growth factor (VEGF) have so far been associated with brain function (Delezie and Handschin, 2018) . CTSB is associated with adult neurogenesis, BDNF levels and memory function (Moon et al., 2016) . In muscle cells Fibronectin type III domain containing 5 (FNDC5) is enzymatically cleaved and secreted as myokine irisin, which can elevate hippocampal BDNF gene expression (Wrann, 2015) . In humans irisin levels in the blood are elevated by exercise (Jedrychowski et al., 2015) . Exercise also increases secretion of VEGF (Hoier et al., 2013 ) from human muscle. In rodents, blocking circulating VEGF (Fabel et al., 2003) or knockdown of VEGF in skeletal muscle (Rich et al., 2017) inhibits the running-induced increase in adult neurogenesis. Our strategy for identifying additional novel myokines secreted by muscle cells, particularly ones that can affect neural function, has centered on compounds that activate AMPK (Moon et al., 2016; Guerrieri et al., 2017) .
Some aspects of exercise (Narkar et al., 2008 ; see however Toedebusch et al., 2016) are partially mimicked by AICAR treatment. This compound has beneficial effects in mouse models of muscle dystrophy (Al-Rewashdy et al., 2015; Brockhoff et al., 2017) , increases adult neurogenesis, BDNF levels and spatial memory function (Kobilo et al., 2011b; Kobilo et al., 2014; Guerrieri and van Praag, 2015) and may alleviate depression-like behavior in mice (Liu et al., 2016) . These effects are likely the indirect consequences of peripheral administration, given the limited permeability of the blood brain barrier (Marangos et al., 1990) , the lack of spatial memory improvement in AMPKDN mice (Kobilo et al., 2014) , and the adverse effects of direct intracranial infusion on synaptic plasticity and spatial memory in rats (Dash et al., 2006) . Furthermore, in vitro studies show that direct treatment of neural stem cells results in gliogenesis, but not neurogenesis (Zang et al., 2008; Zhu et al., 2011) . In our study, culturing differentiating aNPCs in the presence of AICAR-CM increased the proportion of neuronal and glial cells.
Enhancement of neurogenesis and cognitive function by exercise is a complex process that likely involves multiple interacting pathways (Vivar et al., 2013) . While studies of single molecules linked to skeletal muscle have been conducted (Wrann et al., 2013; Agudelo et al., 2014; Moon et al., 2016) , none has examined a combination of factors on neuronal cell function. In this study, we used the differentially expressed fractions from AICAR-treated conditioned medium to begin to investigate whether pools of proteins, associated with specific fractions, may influence cell survival or neurogenesis, two outcomes closely associated with in vivo running-induced neurogenesis (Vivar et al., 2013) . We performed a MTT viability assay and real-time PCR assays to assess the expression of neurogenic markers. We observed that protein fractions from AICAR-treated conditioned media did not affect cell viability as assessed by the MTT assay. However, markers of immature neurons, differentiation and migration, such as Tuj1 and DCX, increased significantly in aNPCs when exposed to fraction A11 of AICAR-treated conditioned media. Our proteomic and bioinformatic analysis identified 38 proteins in fraction A11. Two subgroups of secretory proteins were adhesion junction and focal adhesion proteins, which are both involved in cell-to-cell adhesion dynamics or migration of cells (De Pascalisa and Etienne-Mannevillea, 2017; Mosher and Schaffer, 2017) . Thus, our bioinformatics analysis is consistent with the results of the neuronal differentiation markers.
The fraction included factors such as complement C3 precursors (Shinjyo et al., 2009 ) and fibronectin (Reh and Radke, 1988; Buzanska et al., 2009; Szymczak et al., 2010) that have been reported to play a role in neurogenesis. Immunoblotting showed that fibronectin levels were significantly upregulated in AICAR-CM. In addition, a protein that regulates glucose metabolism, glucose-6-phosphate isomerase (GPI) was present in the fraction. GPI is a multifunctional protein, that is not only a glycolytic enzyme in the cytosol but also serves as a secreted neuroleukin and autocrine motility factor (Jeffrey et al., 2000) that promotes cell proliferation and migration (Zong et al., 2015) . A study showed that GPI is associated with gp78/autocrine motility factor receptor signaling and regulates calcium release from the endoplasmic reticulum, which is important for protein unfolding during neurodegenerative processes (Fu et al., 2011; Hetz and Saxena, 2017) . Furthermore, mutations in GPI have been identified in patients with neuromuscular dysfunction and mental retardation (Schroter et al., 1985) . Our findings suggest a novel function for this protein, enhancing adult neural stem cell differentiation into neurons and glia. Another protein secreted by AICAR-treated cells, ventricular zone-expressed PH protein (VEPH), is expressed in the embryonic mouse brain (Muto et al., 2004) . VEPH is a poorly-characterized protein containing a pleckstrin homology domain. In addition to being expressed in the mouse embryonic brain, expression was also observed in the eye and kidney (Muto et al., 2004) . The amino terminal region of VEPH is highly conserved, suggesting a functional significance. However, VEPH knockout mice do not have any observable abnormalities in the brain, retina or other tissues. VEPH warrants further study, as a potential role in behavior, and in indices of functional and structural brain plasticity have not yet been assessed.
Although we observed a direct effect on neural differentiation mediated by secretory proteins from skeletal muscle, many questions remain unresolved. First, the in vitro system used in this study does not completely reflect the multiple and complex benefits of exercise. Second, the pattern of proteins secreted from the skeletal muscle by AICAR treatment cannot fully represent the whole secretome from various types of skeletal muscles during exercise. Furthermore, recent research suggests that other tissues also play an important role. For instance, adipose tissue-derived cytokines, called adipokines, are regulated by exercise (Golbidi and Laher, 2014) . Adiponectin can enhance adult hippocampal neurogenesis in mice and in cell culture models (Zhang et al., 2011 (Zhang et al., , 2016 and has been suggested to cross the blood-brain barrier to elevate adult neurogenesis in vivo (Yau et al., 2014) . Running-induced neurogenesis and anti-depression-like behavior was not detected in adiponectin knockout mice (Yau et al., 2014) . In addition, ketone bodies secreted from liver (hepatokines), such as exercise-induced beta-hydroxybutyrate (BHA) can increase BDNF expression through HDAC2/HDAC3 inhibition and Histone H3 acetylation in the hippocampus (Sleiman et al., 2016) . Applying pharmacological compounds or molecules that are considered exercise-mimetics (Guerrieri et al., 2017) 2007) to cell cultures of different organs (e.g. muscle, adipose tissue, liver) and analyzing the proteins in the conditioned medium may be an effective approach for revealing novel cellular mechanisms underlying the effects of physical activity on the brain.
Together, we observed that secretory proteins from skeletal muscle induced by AICAR treatment can influence in vitro expression of neuronal differentiation markers. We suggest that secreted proteins from skeletal muscle may play a role in neurogenesis as mediated by enhanced brain function during exercise. Further studies to validate these effects and elucidate the potential mechanism in adult neuronal differentiation during exercise will be of particular interest.
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Fig. 4.
Candidate factor glucose-6-phosphate isomerase (GPI) increases neural differentiation. (A) GPI (0.5 μg/ml and 1 μg/ml), AICAR CM (A-CM) and RA/FSK significantly increased the proportion of aNPCs differentiating into Tuj1-positive neurons as compared to Mock and Vehicle CM (V-CM) treatment conditions (*p < 0.05). (B) GPI (1 μg/ml) and AICAR CM also enhanced gliogenesis as evidenced by an increased number of GFAP-positive astrocytes as compared to Mock and Vehicle CM treatment (*p < 0.05). (C,E,G) Representative photomicrographs of (C) V-CM, (E) A-CM, and (G) GPI treated aNPCs expressing neuronal marker Tuj1 (red), nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI), blue. (D,F,H) Representative photomicrographs of (D) V-CM, (F) A-CM, and (H) GPI treated cells expressing astroglial marker GFAP (red), nuclei were stained with DAPI (blue).
